# Proof of Concept (PoC) Evaluation of Naloxone Unique Intramuscular (IM) Injection

> **NCT07180420** · PHASE1 · COMPLETED · sponsor: **STAT Therapeutics Inc** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteer - Complete

## Interventions

- **DRUG:** naloxone IM

## Key facts

- **NCT ID:** NCT07180420
- **Lead sponsor:** STAT Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-24
- **Primary completion:** 2024-04-08
- **Final completion:** 2024-04-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180420, "Proof of Concept (PoC) Evaluation of Naloxone Unique Intramuscular (IM) Injection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07180420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*